Effipro Duo Spot-on Solution 4 Pipettes 1,34ml 134mg

NAME
EFFIPRO DUO SPOT-ON DOGS

PHARMACOTHERAPEUTIC CATEGORY
Topical ectoparassicides.

ACTIVE PRINCIPLES
Fipronil, pyriproxyphene.

INDICATIONS
Treatment of flea infestations alone or in association with ticks. Against fleas: For the treatment and prevention of flea infestations (Ctenocephalides spp.). The treatment prevents further infestation for 7 weeks. Prevention of flea multiplication by preventing eggs from developing into adult fleas for 12 weeks after application. The product can be used as part of the strategic treatment for the control of flea allergy dermatitis (FAD) when this has been previously diagnosed by the veterinarian. Against ticks: For the treatment of tick infestations (Ixodes ricinus). One treatment has persistent acaricidal effect for 2 weeks Ixodes ricinus and 4 weeks against Dermacentor reticulatus Rhipicephalus sanguineus. If ticks of some species (Dermacentor reticulatus, Rhipicephalus sanguineus) are present when administering the product, not all ticks could be killed within 48 hours.

CONTRAINDICATIONS / SECONDARY EFFECT
Do not use in rabbits, as adverse reactions and even death may occur. Do not use in case of known hypersensitivity to the active substance or to any of the excipients.

USE / ROUTE OF ADMINISTRATION
Topical.

DOSAGE
Dogs 2-10 kg: 0,67 ml pipette. Dogs 10-20 Kg: 1.34 ml pipette. Dogs 20-40 Kg: 2.68 ml pipette. Dogs 40-60 Kg: 4.02 ml pipette. For dogs weighing more than 60 kg the appropriate combination of pipettes should be used. A pipette constitutes a treatment, with the possibility of repeating the administration on a monthly basis. For optimal control of flea and / or tick infestations the treatment program can be based on the local epidemiological situation.

STORAGE
Store at a temperature not exceeding +30 degrees C. Store in a dry place. Keep the blister in the original package in order to protect it from light.

WARNINGS
Shampooing or direct immersion of the animal in water after treatment can reduce the duration of the activity. The product remains active against fleas for 5 weeks when the dog is subjected to monthly washing after treatment. Repeated immersions in water on 2 occasions after application of the product do not affect the adulticidal activity against fleas and the effectiveness of preventing egg development in adult fleas. The influence of water immersion or shampoo on the dog on the efficacy of the product against ticks has not been evaluated. At the beginning of the control measures, in case of infestation, the animal beds, bedding and regular resting areas such as carpets and furnishing fabrics must be treated, with a suitable insecticide and regularly cleaned with a vacuum cleaner. To reduce the presence of fleas in the environment, all animals living in the same home area should be treated with a product suitable for flea control. The product does not prevent the attack of ticks on animals. The transmission of infectious tick-borne diseases cannot be completely excluded if conditions are unfavorable. Immediate efficacy has been demonstrated against Ixodes ricinus, indicating that ticks of this species are killed within 48 hours of product application. If Dermacentor reticulatus or Rhipicephalus sanguineus ticks are present when applying the product, these ticks may not be killed within the first 48 hours. Once dead, the ticks will fall off the animals, any remaining ticks will need to be carefully removed making sure that their portion of the mouthparts does not remain in the skin. For external use only. Animals must be carefully weighed before treatment. In the absence of safety data, the product should not be used in puppies less than 10 weeks of age and / or weighing less than 2 kg. Care should be taken to avoid the contents of the pipette coming into contact with the eyes or mouth of treated dogs. In particular oral uptake due to licking of the application site from treated animals or animals in contact should be avoided. Do not apply the product on wounds or damaged skin. In the absence of further safety studies, do not repeat the treatment at intervals of less than 4 weeks. The use of the product has not been studied in sick and debilitated dogs. Special precautions to be taken by the person administering the product to animals: The product may cause neurotoxicity. The product can be harmful if ingested. Avoid contact with skin and mouth. Avoid ingestion including hand-to-mouth contact. Do not smoke, drink or eat during application. Wash hands after use. Treated animals should not be touched until the application site is dry, and children should not be allowed to play with treated animals until the application site is dry. It is therefore recommended that animals not be treated during the day, but should be treated during the early evening, and that newly treated animals should not be allowed to sleep with their owners, especially children. Keep pipettes in the original packaging until ready for use and dispose of used pipettes immediately. In case of accidental skin contact, rinse with water. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the product label to the physician. Overdose: No adverse reactions were observed in safety studies in target species in puppies of 10 weeks' diet, treated with 5 times the recommended dose 3 times at 4-week intervals and with the maximum recommended dose 6 times at 4-week intervals. 4 weeks. The risk of adverse reactions can 'increase in case of overdose, therefore animals should always be treated with a pipette according to body weight. Incompatibility: None known. Other precautions: Fipronil and pyriproxyphene can adversely affect aquatic organisms. Dogs must be prevented from accessing waterways for 48 hours after treatment. The product can have negative effects on household, painted or other painted surfaces or furnishings. Allow the application site to dry before allowing contact with such materials.

WAITING TIME
Not relevant.

TARGET SPECIES
Dogs.

INTERACTIONS
None known.

SIDE EFFECTS
Transient aesthetic effects such as a wet appearance or a slight appearance of dandruff may occur at the application site. According to the experience accumulated with these active substances among the pharmaceutical forms spots, temporary skin reactions at the application site (squamosis, local alopecia, itching, erythema, discolouration of the skin) and general itching or alopecia can be observed after use. In very rare cases, hypersalivation, reversible neurological symptoms (hyperesthesia, depression, nervous symptoms), respiratory symptoms or vomiting may occur.

PREGNANCY AND BREASTFEEDING
Laboratory studies using fipronil and pyriproxyphene have shown no evidence of teratogenic or embryotoxic effects. The safety of the veterinary medicinal product during pregnancy and lactation has not been established. Use only in accordance with the benefit / risk assessment by the responsible veterinarian.